| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3685602
[patent_doc_number] => 05695944
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-09
[patent_title] => 'Modulation of bcl-2 phosphorylation'
[patent_app_type] => 1
[patent_app_number] => 8/435484
[patent_app_country] => US
[patent_app_date] => 1995-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6265
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/695/05695944.pdf
[firstpage_image] =>[orig_patent_app_number] => 435484
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/435484 | Modulation of bcl-2 phosphorylation | May 4, 1995 | Issued |
Array
(
[id] => 4002475
[patent_doc_number] => 05961978
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'Therapeutically useful peptides and peptide fragments'
[patent_app_type] => 1
[patent_app_number] => 8/433133
[patent_app_country] => US
[patent_app_date] => 1995-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 35
[patent_no_of_words] => 21087
[patent_no_of_claims] => 138
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/961/05961978.pdf
[firstpage_image] =>[orig_patent_app_number] => 433133
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/433133 | Therapeutically useful peptides and peptide fragments | May 2, 1995 | Issued |
| 08/427767 | RECOMBINANT HK2 POLYPEPTIDE | May 1, 1995 | Abandoned |
Array
(
[id] => 4256386
[patent_doc_number] => 06204000
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-20
[patent_title] => 'Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1'
[patent_app_type] => 1
[patent_app_number] => 8/430225
[patent_app_country] => US
[patent_app_date] => 1995-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 8862
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/204/06204000.pdf
[firstpage_image] =>[orig_patent_app_number] => 430225
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/430225 | Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 | Apr 27, 1995 | Issued |
| 08/425682 | HIGH AFFINITY HUMANIZED MONOCLONAL ANTIBODIES | Apr 17, 1995 | Abandoned |
Array
(
[id] => 1277297
[patent_doc_number] => 06645755
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-11
[patent_title] => 'VECTOR MODIFIED BY SEQUENCE CODING FOR A SEQUENCE OF AMINO ACIDS CONTAINED IN A MAMMALIAN PROTEIN HAVING THE BIOLOGICAL ACTIVITY OF A MEMBRANE RECEPTOR, EXPRESSION OF THIS SEQUENCE IN TRANSFORMED UNICELLULAR CULTURES BY MEANS OF THIS VECTOR, PROCEDURE FOR STUDYING LIGANDS RECOGNIZING THESE RECEPTORS'
[patent_app_type] => B1
[patent_app_number] => 08/422612
[patent_app_country] => US
[patent_app_date] => 1995-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 8537
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/645/06645755.pdf
[firstpage_image] =>[orig_patent_app_number] => 08422612
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/422612 | VECTOR MODIFIED BY SEQUENCE CODING FOR A SEQUENCE OF AMINO ACIDS CONTAINED IN A MAMMALIAN PROTEIN HAVING THE BIOLOGICAL ACTIVITY OF A MEMBRANE RECEPTOR, EXPRESSION OF THIS SEQUENCE IN TRANSFORMED UNICELLULAR CULTURES BY MEANS OF THIS VECTOR, PROCEDURE FOR STUDYING LIGANDS RECOGNIZING THESE RECEPTORS | Apr 12, 1995 | Issued |
Array
(
[id] => 3655363
[patent_doc_number] => 05658742
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-19
[patent_title] => 'Monoclonal antibody'
[patent_app_type] => 1
[patent_app_number] => 8/404643
[patent_app_country] => US
[patent_app_date] => 1995-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 7745
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/658/05658742.pdf
[firstpage_image] =>[orig_patent_app_number] => 404643
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/404643 | Monoclonal antibody | Mar 14, 1995 | Issued |
Array
(
[id] => 3947152
[patent_doc_number] => 05955289
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Assays for nongenotoxic, chemical carcinogens'
[patent_app_type] => 1
[patent_app_number] => 8/400401
[patent_app_country] => US
[patent_app_date] => 1995-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 73
[patent_no_of_words] => 16868
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955289.pdf
[firstpage_image] =>[orig_patent_app_number] => 400401
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/400401 | Assays for nongenotoxic, chemical carcinogens | Mar 6, 1995 | Issued |
Array
(
[id] => 3648535
[patent_doc_number] => 05605804
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-25
[patent_title] => 'Diagnosis and monitoring of lung cancer patients by measurement of NCA 50/90 in blood'
[patent_app_type] => 1
[patent_app_number] => 8/400152
[patent_app_country] => US
[patent_app_date] => 1995-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 4905
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/605/05605804.pdf
[firstpage_image] =>[orig_patent_app_number] => 400152
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/400152 | Diagnosis and monitoring of lung cancer patients by measurement of NCA 50/90 in blood | Mar 6, 1995 | Issued |
| 08/400213 | DIAGNOSIS AND MONITORING OF COLON CANCER PATIENTS BY MEASUREMENT OF NCA 50/90 IN BLOOD | Mar 6, 1995 | Abandoned |
Array
(
[id] => 4044390
[patent_doc_number] => 05869238
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-09
[patent_title] => 'Quantitative method of measuring metastatic activity'
[patent_app_type] => 1
[patent_app_number] => 8/390904
[patent_app_country] => US
[patent_app_date] => 1995-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 5431
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/869/05869238.pdf
[firstpage_image] =>[orig_patent_app_number] => 390904
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/390904 | Quantitative method of measuring metastatic activity | Feb 15, 1995 | Issued |
Array
(
[id] => 3660071
[patent_doc_number] => 05624799
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-29
[patent_title] => 'Cancer-associated mar binding protein'
[patent_app_type] => 1
[patent_app_number] => 8/388023
[patent_app_country] => US
[patent_app_date] => 1995-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7974
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/624/05624799.pdf
[firstpage_image] =>[orig_patent_app_number] => 388023
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/388023 | Cancer-associated mar binding protein | Feb 12, 1995 | Issued |
Array
(
[id] => 3645140
[patent_doc_number] => 05637471
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-10
[patent_title] => 'Therapeutic and diagnostic methods and compositions based on transducin-like enhancer of split proteins and nucleic acids'
[patent_app_type] => 1
[patent_app_number] => 8/385207
[patent_app_country] => US
[patent_app_date] => 1995-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 43
[patent_no_of_words] => 27116
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/637/05637471.pdf
[firstpage_image] =>[orig_patent_app_number] => 385207
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/385207 | Therapeutic and diagnostic methods and compositions based on transducin-like enhancer of split proteins and nucleic acids | Feb 6, 1995 | Issued |
| 08/384543 | DIAGNOSTICS BASED ON DNA DUPLEX REPAIR | Feb 6, 1995 | Abandoned |
Array
(
[id] => 3685736
[patent_doc_number] => 05643736
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-01
[patent_title] => 'Monoclonal antibodies for human osteogenic cell surface antigens'
[patent_app_type] => 1
[patent_app_number] => 8/384039
[patent_app_country] => US
[patent_app_date] => 1995-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 9899
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/643/05643736.pdf
[firstpage_image] =>[orig_patent_app_number] => 384039
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/384039 | Monoclonal antibodies for human osteogenic cell surface antigens | Feb 5, 1995 | Issued |
| 08/382876 | METHODS FOR THE DETECTION OF PRO-CATHEPSINS AND USES THEREOF | Feb 2, 1995 | Abandoned |
Array
(
[id] => 3865780
[patent_doc_number] => 05837474
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Immunological method for the detection of malignant tumors and kit for performing the method'
[patent_app_type] => 1
[patent_app_number] => 8/295720
[patent_app_country] => US
[patent_app_date] => 1995-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 3607
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837474.pdf
[firstpage_image] =>[orig_patent_app_number] => 295720
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/295720 | Immunological method for the detection of malignant tumors and kit for performing the method | Jan 29, 1995 | Issued |
Array
(
[id] => 3588488
[patent_doc_number] => 05520914
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-28
[patent_title] => 'Antibodies to angiogenin: immunotherapeutic agents'
[patent_app_type] => 1
[patent_app_number] => 8/377666
[patent_app_country] => US
[patent_app_date] => 1995-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4688
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/520/05520914.pdf
[firstpage_image] =>[orig_patent_app_number] => 377666
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/377666 | Antibodies to angiogenin: immunotherapeutic agents | Jan 23, 1995 | Issued |
Array
(
[id] => 3986302
[patent_doc_number] => 05910418
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-08
[patent_title] => 'Antibodies and assay for detecting mutant APC proteins'
[patent_app_type] => 1
[patent_app_number] => 8/370235
[patent_app_country] => US
[patent_app_date] => 1995-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 12
[patent_no_of_words] => 18158
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/910/05910418.pdf
[firstpage_image] =>[orig_patent_app_number] => 370235
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/370235 | Antibodies and assay for detecting mutant APC proteins | Jan 8, 1995 | Issued |
| 08/368403 | ANTIBODIES WHICH BIND TO HUMAN CYCLIN A AND THEIR USE IN DETECTION OF CELL PROLIFERATION | Jan 2, 1995 | Abandoned |